title: Clinical pharmacokinetics of phenobarbital in neonates.
abstract: Demographic and clinical pharmacokinetic data collected from term and preterm neonates who were treated with intravenous phenobarbital have been analysed to evaluate the role of patient characteristics in pharmacokinetic parameters. Significant relationships between total body weight (TBW) or body surface area (BSA) and volume of distribution (Vd) and total body clearance (CL) were found. Coefficients of determination were: 0.55 and 0.59 for Vd, and 0.76 and 0.72 for CL against TBW and BSA, respectively. In addition, significant relationships between height of the infants and volume of distribution of phenobarbital and total body clearance were observed. Coefficients of determination were 0.58 for Vd and 0.56 for CL. A weaker but significant correlation existed between gestational age and Vd or CL of phenobarbital. Coefficients of determination were 0.43 and 0.64, respectively. There was no correlation between volume of distribution per kg body weight or total body clearance per kg body weight and any patient parameter investigated. However, these latter pharmacokinetic parameters tended to decrease with increasing gestational age and height of the neonates. The results obtained were used to develop new loading and maintenance doses for phenobarbital in neonates based on total body weight and body surface area and based on height and gestational age for cases that weight is not available.
authors: Department of Pharmacy, Vrije Universiteit Medical Centre, De Boelelaan 1117, NL-1081 HV, Amsterdam, The Netherlands. djtouw@hotmail.com
authors: D J
authors: DJ
authors: Touw
authors: O
authors: O
authors: Graafland
authors: A
authors: A
authors: Cranendonk
authors: R J
authors: RJ
authors: Vermeulen
authors: M M
authors: MM
authors: van Weissenbruch
mesh_terms: D000927:Anticonvulsants / Q000008:administration & dosage / Q000493:pharmacokinetics* / Q000627:therapeutic use; D001824:Body Constitution; D020936:Epilepsy, Benign Neonatal / Q000097:blood / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D007234:Infant, Premature; D007262:Infusions, Intravenous; D008297:Male; D008657:Metabolic Clearance Rate; D010634:Phenobarbital / Q000008:administration & dosage / Q000493:pharmacokinetics* / Q000627:therapeutic use; D012044:Regression Analysis
chemical_list: D000927:Anticonvulsants; D010634:Phenobarbital